Clearstead Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.04M | Buy |
14,671
+979
| +7% | +$270K | 0.06% | 215 |
|
|
2025
Q1 | $3.63M | Buy |
13,692
+295
| +2% | +$78.3K | 0.06% | 216 |
|
|
2024
Q4 | $3.11M | Sell |
13,397
-292
| -2% | -$67.8K | 0.05% | 233 |
|
|
2024
Q3 | $3.02M | Buy |
13,689
+209
| +2% | +$46.1K | 0.05% | 240 |
|
|
2024
Q2 | $2.65M | Buy |
13,480
+1,418
| +12% | +$279K | 0.05% | 243 |
|
|
2024
Q1 | $2.53M | Buy |
12,062
+517
| +4% | +$109K | 0.13% | 134 |
|
|
2023
Q4 | $2.43M | Sell |
11,545
-10,905
| -49% | -$2.3M | 0.13% | 134 |
|
|
2023
Q3 | $4.49M | Buy |
22,450
+11,401
| +103% | +$2.28M | 0.13% | 131 |
|
|
2023
Q2 | $2.05M | Buy |
11,049
+9,524
| +625% | +$1.76M | 0.12% | 141 |
|
|
2023
Q1 | $292K | Buy |
1,525
+1,035
| +211% | +$198K | 0.02% | 341 |
|
|
2022
Q4 | $82.4K | Sell |
490
-45
| -8% | -$7.57K | 0.01% | 535 |
|
|
2022
Q3 | $95K | Buy |
535
+24
| +5% | +$4.26K | 0.01% | 484 |
|
|
2022
Q2 | $105K | Buy |
511
+22
| +4% | +$4.52K | 0.01% | 492 |
|
|
2022
Q1 | $116K | Buy |
489
+483
| +8,050% | +$115K | 0.01% | 515 |
|
|
2021
Q4 | $1K | Sell |
6
-22
| -79% | -$3.67K | ﹤0.01% | 1160 |
|
|
2021
Q3 | $5K | Buy |
28
+5
| +22% | +$893 | ﹤0.01% | 1013 |
|
|
2021
Q2 | $5K | Buy |
+23
| New | +$5K | ﹤0.01% | 877 |
|
|
2020
Q4 | – | Sell |
-50
| Closed | -$8K | – | 985 |
|
|
2020
Q3 | $8K | Buy |
+50
| New | +$8K | ﹤0.01% | 690 |
|